Chemotherapy and survival in colorectal cancer patients with and without microsatellite instability: Can MSI be a prognostic marker? Reply

被引：1
作者：
Carethers, JM [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Gastroenterol, San Diego, CA 92103 USA
来源：
GASTROENTEROLOGY | 2004年 / 127卷 / 02期
关键词：
D O I：
10.1053/j.gastro.2004.06.040
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：689 / 690
页数：2
相关论文
共 4 条
[1]  
Boland CR, 1998, CANCER RES, V58, P5248
[2]   Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer [J].
Carethers, JM ;
Smith, EJ ;
Behling, CA ;
Nguyen, L ;
Tajima, A ;
Doctolero, RT ;
Cabrera, BL ;
Goel, M ;
Arnold, CA ;
Miyai, K ;
Boland, CR .
GASTROENTEROLOGY, 2004, 126 (02) :394-401
[3]   Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer [J].
Ribic, CM ;
Sargent, DJ ;
Moore, MJ ;
Thibodeau, SN ;
French, AJ ;
Goldberg, RM ;
Hamilton, SR ;
Laurent-Puig, P ;
Gryfe, R ;
Shepherd, LE ;
Tu, D ;
Redston, M ;
Gallinger, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (03) :247-257
[4]   Molecular predictors of survival after adjuvant chemotherapy for colon cancer. [J].
Watanabe, T ;
Wu, T ;
Catalano, PJ ;
Ueki, T ;
Satriano, R ;
Benson, AB ;
Hamilton, SR .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (16) :1196-1206
1